157 related articles for article (PubMed ID: 16399992)
1. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
Juul K; Tybjaerg-Hansen A; Marklund S; Lange P; Nordestgaard BG
Am J Respir Crit Care Med; 2006 Apr; 173(8):858-64. PubMed ID: 16399992
[TBL] [Abstract][Full Text] [Related]
2. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.
Juul K; Tybjaerg-Hansen A; Marklund S; Heegaard NH; Steffensen R; Sillesen H; Jensen G; Nordestgaard BG
Circulation; 2004 Jan; 109(1):59-65. PubMed ID: 14662715
[TBL] [Abstract][Full Text] [Related]
3. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations.
Dahl M; Bowler RP; Juul K; Crapo JD; Levy S; Nordestgaard BG
Am J Respir Crit Care Med; 2008 Nov; 178(9):906-12. PubMed ID: 18703790
[TBL] [Abstract][Full Text] [Related]
4. Superoxide dismutases, lung function and bronchial responsiveness in a general population.
Siedlinski M; van Diemen CC; Postma DS; Vonk JM; Boezen HM
Eur Respir J; 2009 May; 33(5):986-92. PubMed ID: 19213780
[TBL] [Abstract][Full Text] [Related]
5. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
6. [Superoxide dismutase gene polymorphisms and functional activity in chronic obstructive pulmonary disease].
Guo F; Kuang JL
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):424-8. PubMed ID: 21781513
[TBL] [Abstract][Full Text] [Related]
7. Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study.
Dahl M; Tybjaerg-Hansen A; Lange P; Nordestgaard BG
Respir Res; 2005 Oct; 6(1):113. PubMed ID: 16212675
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals.
Bækvad-Hansen M; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Apr; 37(4):791-9. PubMed ID: 20693256
[TBL] [Abstract][Full Text] [Related]
9. β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.
Thomsen M; Nordestgaard BG; Sethi AA; Tybjærg-Hansen A; Dahl M
Eur Respir J; 2012 Mar; 39(3):558-66. PubMed ID: 22075484
[TBL] [Abstract][Full Text] [Related]
10. Does SOD3 R213G Homozygosity Influence Morbidity, Mortality, and Lung Function in the General Population?
Kobylecki CJ; Afzal S; Nordestgaard BG
Antioxid Redox Signal; 2016 May; 24(15):884-91. PubMed ID: 26901385
[TBL] [Abstract][Full Text] [Related]
11. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
[TBL] [Abstract][Full Text] [Related]
12. EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis.
Lee J; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Jan; 37(1):18-25. PubMed ID: 20516053
[TBL] [Abstract][Full Text] [Related]
13. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function.
Young RP; Hopkins R; Black PN; Eddy C; Wu L; Gamble GD; Mills GD; Garrett JE; Eaton TE; Rees MI
Thorax; 2006 May; 61(5):394-9. PubMed ID: 16467073
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.
Dahl M; Tybjaerg-Hansen A; Vestbo J; Lange P; Nordestgaard BG
Am J Respir Crit Care Med; 2001 Sep; 164(6):1008-11. PubMed ID: 11587987
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation.
Stanojkovic I; Kotur-Stevuljevic J; Milenkovic B; Spasic S; Vujic T; Stefanovic A; Llic A; Ivanisevic J
Respir Med; 2011 Oct; 105 Suppl 1():S31-7. PubMed ID: 22015083
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease.
Kirkil G; Hamdi Muz M; Seçkin D; Sahin K; Küçük O
Respir Med; 2008 Jun; 102(6):840-4. PubMed ID: 18295467
[TBL] [Abstract][Full Text] [Related]
17. Genetically Low Antioxidant Protection and Risk of Cardiovascular Disease and Heart Failure in Diabetic Subjects.
Kobylecki CJ; Afzal S; Nordestgaard BG
EBioMedicine; 2015 Dec; 2(12):2010-5. PubMed ID: 26844281
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD.
Mak JC; Ho SP; Yu WC; Choo KL; Chu CM; Yew WW; Lam WK; Chan-Yeung M
Eur Respir J; 2007 Oct; 30(4):684-90. PubMed ID: 17567676
[TBL] [Abstract][Full Text] [Related]
19. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
20. Decline in FEV1 related to genetic polymorphisms (+138insA/delA and Lys198Asn) of the endothelin-1 gene in COPD. A pilot study.
Kaparianos A; Argyropoulou E; Efremidis G; Flordellis C; Spiropoulos K
Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):705-19. PubMed ID: 20707291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
